GlassScriptPhysician profile
Sandra L Pruett
NPI 1750515649
$1,092.49
in general payments reported to CMS, 2019-2025
17 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.39 · 2022: $178 · 2023: $384 · 2024: $316 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $472.42 | 2023-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $145.88 | 2023 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $143.67 | 2022-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $55.36 | 2024 | |
| Novartis Pharmaceuticals Corporation | $47.30 | 2022 | |
| Edwards Lifesciences Corporation | $26.63 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $25.00 | 2021 | |
| Cardiva Medical, INC. | $24.78 | 2024 | Savvywire |
| Baxter Healthcare | $24.69 | 2025 | Preveleak |
| La Jolla Pharmaceutical Company | $19.91 | 2024 | Giapreza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.38 | 2024 | Lifevest |
| Takeda Pharmaceuticals U.S.A., INC. | $17.13 | 2025 | Trintellix |
| Abbott Laboratories | $16.75 | 2022 | |
| Aroa Biosurgery Incorporated | $16.47 | 2024 | |
| Medela LLC | $14.56 | 2025 | Thopaz |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $12.39 | 2021 | |
| Merck Sharp & Dohme LLC | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Pruett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.